Cancer HealthCast: This AI Tool Could Predict a Patient’s Response to Immunotherapy
NCI cancer researcher highlights how AI is playing a pivotal role in cancer care.
Artificial intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.
Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).
Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.
-
Dr. Eytan Ruppin Chief, Cancer Data Science Lab NCI
-
AI Revolutionizes Cybersecurity by Doing What Humans Cannot
Leaders from NSA, GAO and industry say that artificial intelligence can augment the cybersecurity workforce, but the work must be auditable and explainable.
4m read -
Elevating Cybersecurity in the Intelligence Community
The Intelligence Community is developing strategies to protect data and strengthen resiliency against emerging cyber threats.
30m watch -
Agencies Prioritize Pilots, Literacy to Overcome AI Challenges
DOL and HUD focus on change management and AI literacy to overcome adoption challenges and boost operational efficiency.
5m read -
Responsible AI Development Requires Risk Management
Officials emphasize the importance of addressing bias, data quality and civil liberties in AI implementation.
4m read
